NanoXplore Announces Results of Annual Meeting of Shareholders

NanoXplore Inc. ("NanoXplore" or the "Company") ( TSX: GRA and OTCQX: NNXPF ), a world-leading graphene company, held its Annual Meeting of Shareholders (the "Meeting") virtually on December 22, 2021. Altogether, 85,364,604 shares (53.99% of outstanding common shares) were accounted for at the Meeting. As part of the formal proceedings, the Company's shareholders elected the Board of Directors and approved the appointment of PricewaterhouseCoopers LLP as independent auditor of the Company. The complete voting results from the Meeting are presented below.

Election of Directors

The Board of Directors fixed at eight the number of directors of the Company to be elected at the Meeting. Each of the eight nominees listed in the Management Information Circular was elected as a director of NanoXplore.   All of the nominee directors were already members of the Board of Directors of the Company.

Nominee Votes For % For Votes Withheld % Withheld
Rob Wildeboer 82,313,650 99.99% 9,200 0.01%
Benoît Gascon 81,089,450 98.50% 1,233,400 1.50%
Soroush Nazarpour 82,318,900 99.99% 3,950 0.01%
Cameron Harris 82,317,650 99.99% 5,200 0.01%
Denis Labrecque 80,999,157 98.39% 1,323,693 1.61%
Arinder S. Mahal 82,188,217 99.84% 134,633 0.16%
Jodie Morgan 82,197,767 99.85% 125,083 0.15%
Nathalie Pilon 82,312,100 99.99% 10,750 0.01%

Appointment of Independent Auditor

PricewaterhouseCoopers LLP, Chartered Professional Accountants, was reappointed as independent auditor of NanoXplore until the close of the next Annual mMeeting of Shareholders, and the directors were authorized to fix the remuneration of the auditor.

Votes For % For Votes Withheld % Withheld
84,344,155 99.98% 18,539 0.02%

About NanoXplore

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities in Canada, the United States and Europe.

For more information, please contact:

Soroush Nazarpour
President & CEO
NanoXplore Inc.
info@NanoXplore.ca
(514) 935-1377


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GRA:CA,NNXPF
The Conversation (0)
Longeveron Granted Small or Medium-sized Enterprise  Status by the European Medicines Agency

Longeveron Granted Small or Medium-sized Enterprise Status by the European Medicines Agency

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has been granted Small or Medium-sized Enterprise (SME) status by the European Medicines... Keep Reading...
Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Contract manufacturing services as a new business line has the potential to generate approximately $4-5 million in annual revenues First manufacturing services contract signed with Secretome Therapeutics Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company... Keep Reading...
Immatics Announces First Quarter 2024 Financial Results and Business Update

Immatics Announces First Quarter 2024 Financial Results and Business Update

Company Provides Clinical Data Update from Ongoing Phase 1 Clinical Trial with ACTengine® IMA203 TCR-T Targeting PRAME Updated clinical data on ACTengine® IMA203 targeting PRAME in 30 heavily pre-treated metastatic melanoma patients at RP2D: 55% confirmed objective response rate, including tumor... Keep Reading...
Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce an innovative research initiative to be undertaken with The Giacomantonio Immuno-Oncology Research Group (the "Research Group"). This study aims to evaluate the efficacy of Sona's Targeted... Keep Reading...

Why Invest in Nanotech Stocks?

The nanotechnology market is experiencing a promising stage of growth, making it an attractive space for investors.From nanotech-based solar panels that increase energy efficiency to pharmaceutical products that make use of nanotech in drug-delivery systems, nanotechnology has far-reaching... Keep Reading...

SILO Pharma Inc

SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. Keep Reading...

Interactive Chart

Latest Press Releases

Related News